Profile
QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary nanoparticle platform. The platform technology enables antibody-guided targeting and active transportation across the blood-brain barrier, with broad payload flexibility (siRNA/mRNA, peptides, chemo agents). The company's lead asset is a first-in-class therapeutic agent on the cusp of IND that can modify the tumour microenvironment and turn cold tumours hot.
Website
www.qurcan.comContact
-
Dr. Mohammad Ali Amini, President & CEOTel: +1 647-447-7449Email: ma.amini@qurcan.com
Event details
Date: September 21 - 23, 2022
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
10 in total
-
Able Innovations is solving the repetitive and labour-intensive task of patient transfers by developing robotic medical… -
Cohesys is a Toronto-based medical device manufacturer that has developed BoneTape, a resorbable tape for bone fracture… -
EmergConnect aims to change the way patients think about same-day care through a digital platform for patient self-… -
Hyivy Health was created after founder Rachel Bartholomew’s recent fight with cervical cancer. She wanted to change the… -
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists… -
ProteinQure has built the best computational platform for designing small exotic protein therapeutics. ProteinQure… -
QuadroCore is pushing the limits within the field of Mass Spectrometer (MS) technology. The company is… -
QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary…
-
Quthero is an early-stage life sciences startup developing applications for its platform technology--a unique, patented… -
Translucent Computing’s Emrchiver enables value-based care for better patient outcomes without vendor lock-in.…